Selected Publications
Bear AS, Blanchard T, Cesare J, Ford MJ, Richman LP, Xu C, Baroja ML, McCuaig S, Costeas C, Gabunia K, Scholler J, Posey AD Jr, O'Hara MH, Smole A, Powell DJ Jr, Garcia BA, Vonderheide RH, Linette GP, Carreno BM.: Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nat Commun 12: 4365, Jul 2021.Bear AS, Fraietta JA, Narayan VK, O'Hara M, Haas NB.: Adoptive Cellular Therapy for Solid Tumors. Am Soc Clin Oncol Educ Book 2021.
Bear AS, Vonderheide RH, O'Hara MH.: Challenges and Opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell 38: 788-802, Dec 2020.
Vonderheide RH, Bear AS.: Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer. Front Immunol 11: 605619, Nov 2020.
Bear AS, Hanley PJ, Bosque DM, Cruz CR, Kaur I, Liu H, Kebriaei P, Hosing C, Rezvani K, Oran B, De Lima MJ, Bollard CM, Shpall EJ.: Low rate of infusional toxicity after expanded cord blood transplantation. Cytotherapy 2014.
Bear AS, Kennedy LC, Young JK, Perna SK, Mattos Almeida JP, Lin AY, Eckels PC, Drezek RA, Foster AE.: Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer. PLoS One 8: e69073, Jul 2013.
Lin AY, Lunsford J, Bear AS, Young JK, Eckels P, Luo L, Foster AE, Drezek RA.: High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro. Nanoscale Res Lett 8: 72, Feb 2013.
Cruz CR, Lam S, Hanley PJ, Bear AS, Langston C, Cohen AJ, Liu H, Martinez CA, Krance RA, Heslop HE, Rooney CM, Hanson IC, Bollard CM.: Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clin Exp Immunol 2013.
Doherty JE, Woodard LE, Bear AS, Foster AE, Wilson MH.: An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression. FASEB J 2013.
Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G.: Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther 2012.